VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare
VistaGen Therapeutics Inc. Total Liabilities 2011–2025
VistaGen Therapeutics Inc. annual total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- VistaGen Therapeutics Inc. total liabilities as of March 31, 2025: 14.0M, a 48.94% increase year-over-year.
- VistaGen Therapeutics Inc. total liabilities for 2025 were 14.0M, a 48.94% increase from 2024.
- VistaGen Therapeutics Inc. total liabilities for 2024 were 9.4M, a 3.97% increase from 2023.
- VistaGen Therapeutics Inc. total liabilities for 2023 were 9.0M, a 9.26% decrease from 2022.
- VistaGen Therapeutics Inc. total liabilities for 2022 were 9.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| VistaGen Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $9 |
| 2023 | $9 |
| 2022 | $10 |
| 2021 | $16 |
| 2020 | $12 |
| 2018 | $4 |
| 2017 | $3 |
| 2016 | $4 |
| 2013 | $13 |
| 2012 | $13 |
| 2011 | $19 |
VistaGen Therapeutics Inc. Total Liabilities — FAQ
VistaGen Therapeutics Inc. (VTGN) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VTGN's total liabilities history?
The chart and table above show VistaGen Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.